Skip to main content
OpenTrials

Clinical trial condition

Muscular Atrophy, Spinal

Explore clinical trials studying Muscular Atrophy, Spinal. Study availability and eligibility vary by location and protocol.

56 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Muscular Atrophy, Spinal trial results

Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

NCT07723248

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Urology Specialists of the Carolinas - University Place Charlotte, North Carolina, United States
  • Summit Urology Murray, Utah, United States
  • First Urology PSC Jeffersonville, Indiana, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details
Recruiting

A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

NCT07554924

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Recruiting

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

NCT07336446

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Research Site Duarte, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07190300

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Uni Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Wichita Urology Group PA Wichita, Kansas, United States
View all 31 locations
View Trial Details
Recruiting

Test of Aquatic Mobility of SMA Infants

NCT06152302

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +14 more
Locations
  • Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP Garches, France
View Trial Details

Related conditions